Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Meessen

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
European Heart Journal. Quality of Care & Clinical Outcomes|June 20, 2020
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registryLeonardo De Luca, Dario Formigli, Jennifer Meessen, et al.
Critical Care (London, England)|September 29, 2018
Septic shock-3 vs 2: an analysis of the ALBIOS studyFrancesco Vasques, Eleonora Duscio, Federica Romitti, et al.
ESC Heart Failure|July 7, 2020
Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI-HF trialGiovanni Targher, Gianluigi Lunardi, Alessandro Mantovani, et al.
European Heart Journal. Digital Health|May 25, 2026
Automated full-text screening and accelerated reviews using large language models with context-aware agents: an exploratory analysis in biomarker researchYongxin Ye, Martina Colombo, Jennifer Meessen, et al.
Critical Care (London, England)|March 25, 2026
Clinical utility of proenkephalin A 119-159 for prediction of worsening renal function and prognosis in patients with sepsis -results of a patient-level meta-analysisBirte Arlt, Pietro Caironi, Jennifer Meessen, et al.
Journal of Critical Care|February 26, 2021
Albumin replacement therapy in immunocompromised patients with sepsis - Secondary analysis of the ALBIOS trialAndrea Cortegiani, Giacomo Grasselli, Jennifer Meessen, et al.
European Journal of Clinical Investigation|June 26, 2020
The role of resistin and myeloperoxidase in severe sepsis and septic shock: Results from the ALBIOS trialAldo Bonaventura, Federico Carbone, Alessandra Vecchié, et al.
Shock (Augusta, Ga.)|September 17, 2020
Pentraxin-3, Troponin T, N-Terminal Pro-B-Type Natriuretic Peptide in Septic PatientsFrancesco Vassalli, Serge Masson, Jennifer Meessen, et al.
American Journal of Respiratory and Critical Care Medicine|April 16, 2019
Understanding Lactatemia in Human Sepsis. Potential Impact for Early ManagementLuciano Gattinoni, Francesco Vasques, Luigi Camporota, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 25, 2020
External applicability of the ISCHEMIA trial: an analysis of a prospective, nationwide registry of patients with stable coronary artery diseaseLeonardo De Luca, Massimo Uguccioni, Jennifer Meessen, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
European Heart Journal. Quality of Care & Clinical Outcomes|June 20, 2020
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registryLeonardo De Luca, Dario Formigli, Jennifer Meessen, et al.
Critical Care (London, England)|September 29, 2018
Septic shock-3 vs 2: an analysis of the ALBIOS studyFrancesco Vasques, Eleonora Duscio, Federica Romitti, et al.
ESC Heart Failure|July 7, 2020
Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI-HF trialGiovanni Targher, Gianluigi Lunardi, Alessandro Mantovani, et al.
European Heart Journal. Digital Health|May 25, 2026
Automated full-text screening and accelerated reviews using large language models with context-aware agents: an exploratory analysis in biomarker researchYongxin Ye, Martina Colombo, Jennifer Meessen, et al.
Critical Care (London, England)|March 25, 2026
Clinical utility of proenkephalin A 119-159 for prediction of worsening renal function and prognosis in patients with sepsis -results of a patient-level meta-analysisBirte Arlt, Pietro Caironi, Jennifer Meessen, et al.
Journal of Critical Care|February 26, 2021
Albumin replacement therapy in immunocompromised patients with sepsis - Secondary analysis of the ALBIOS trialAndrea Cortegiani, Giacomo Grasselli, Jennifer Meessen, et al.
European Journal of Clinical Investigation|June 26, 2020
The role of resistin and myeloperoxidase in severe sepsis and septic shock: Results from the ALBIOS trialAldo Bonaventura, Federico Carbone, Alessandra Vecchié, et al.
Shock (Augusta, Ga.)|September 17, 2020
Pentraxin-3, Troponin T, N-Terminal Pro-B-Type Natriuretic Peptide in Septic PatientsFrancesco Vassalli, Serge Masson, Jennifer Meessen, et al.
American Journal of Respiratory and Critical Care Medicine|April 16, 2019
Understanding Lactatemia in Human Sepsis. Potential Impact for Early ManagementLuciano Gattinoni, Francesco Vasques, Luigi Camporota, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 25, 2020
External applicability of the ISCHEMIA trial: an analysis of a prospective, nationwide registry of patients with stable coronary artery diseaseLeonardo De Luca, Massimo Uguccioni, Jennifer Meessen, et al.
Pageof 4